DrugMapper


Display Options: Drug type Therapeutic Area Route of administration Mechanism of Action Indication Status		Total: 61


Small molecule Approved DIABETES DRUGS & ENDOCRINOLOGY; OTHER ORAL HIV Infections; Central Nervous System Neoplasms; Head and Neck Neoplasms; Heart Failure; Leukoplakia, Oral; Non-alcoholic Fatty Liver Disease; Pituitary ACTH Hypersecretion; Sarcoma; Atherosclerosis; Insulin Resistance; Diabetes Mellitus; Diabetes Mellitus, Type 2 Peroxisome proliferator-activated receptor gamma agonist


Small molecule Approved DIABETES DRUGS & ENDOCRINOLOGY; OTHER; UROLOGY AND KIDNEY INJECTION; ORAL Neoplasms; Prostatic Neoplasms, Castration-Resistant; Psoriasis; Hyperparathyroidism, Secondary; Parathyroid Diseases; Renal Insufficiency, Chronic Vitamin D receptor agonist


Small molecule Approved DIABETES DRUGS & ENDOCRINOLOGY; OTHER ORAL Carcinoma, Intraductal, Noninfiltrating; Tobacco Use Disorder; Anxiety; Breast Neoplasms, Male; Diabetes Mellitus; Persian Gulf Syndrome; Pregnancy; Prostatic Neoplasms, Castration-Resistant; Adenomyosis; Alcoholism; Alzheimer Disease; Bipolar Disorder; Borderline Personality Disorder; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Central Serous Chorioretinopathy; Cocaine-Related Disorders; Endometrial Neoplasms; Endometriosis; Fallopian Tube Neoplasms; Hepatitis C; HIV Infections; Ovarian Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms; Stress Disorders, Post-Traumatic; Abortion, Spontaneous; Depressive Disorder; Depressive Disorder, Major; Leiomyoma; Meningioma; Pituitary ACTH Hypersecretion; Cushing Syndrome Glucocorticoid receptor antagonist

Small molecule

Approved

DIABETES DRUGS & ENDOCRINOLOGY; OTHER

ORAL

Carcinoma, Intraductal, Noninfiltrating; Tobacco Use Disorder; Anxiety; Breast Neoplasms, Male; Diabetes Mellitus; Persian Gulf Syndrome; Pregnancy; Prostatic Neoplasms, Castration-Resistant; Adenomyosis; Alcoholism; Alzheimer Disease; Bipolar Disorder; Borderline Personality Disorder; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Central Serous Chorioretinopathy; Cocaine-Related Disorders; Endometrial Neoplasms; Endometriosis; Fallopian Tube Neoplasms; Hepatitis C; HIV Infections; Ovarian Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms; Stress Disorders, Post-Traumatic; Abortion, Spontaneous; Depressive Disorder; Depressive Disorder, Major; Leiomyoma; Meningioma; Pituitary ACTH Hypersecretion; Cushing Syndrome

Glucocorticoid receptor antagonist


Small molecule Approved CANCER; DIABETES DRUGS & ENDOCRINOLOGY; MUSCULOSKELETAL; OTHER INJECTION; INTRAVENOUS; IV (INFUSION) Adenocarcinoma; Anemia, Sickle Cell; Chondrosarcoma; Menopause; Neuroblastoma; beta-Thalassemia; Carcinoma, Hepatocellular; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Renal Cell; Complex Regional Pain Syndromes; Kidney Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Low Back Pain; Macular Degeneration; Mesothelioma; Nasopharyngeal Neoplasms; Osteosarcoma; Primary Myelofibrosis; Progeria; Urogenital Neoplasms; Uterine Cervical Neoplasms; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Bone Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Fractures, Bone; Giant Cell Tumors; Lung Neoplasms; Lymphoma, Non-Hodgkin; Osteoarthritis, Hip; Osteogenesis Imperfecta; Osteonecrosis; Pain; Plasmacytoma; Reflex Sympathetic Dystrophy; Sarcoma; Sarcoma, Ewing; Spinal Cord Injuries; Bone Diseases; Multiple Myeloma; Neoplasm Metastasis; Osteitis Deformans; Osteoporosis; Osteoporosis, Postmenopausal; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant Farnesyl diphosphate synthase inhibitor

Small molecule

Approved

CANCER; DIABETES DRUGS & ENDOCRINOLOGY; MUSCULOSKELETAL; OTHER

INJECTION; INTRAVENOUS; IV (INFUSION)

Adenocarcinoma; Anemia, Sickle Cell; Chondrosarcoma; Menopause; Neuroblastoma; beta-Thalassemia; Carcinoma, Hepatocellular; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Renal Cell; Complex Regional Pain Syndromes; Kidney Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Low Back Pain; Macular Degeneration; Mesothelioma; Nasopharyngeal Neoplasms; Osteosarcoma; Primary Myelofibrosis; Progeria; Urogenital Neoplasms; Uterine Cervical Neoplasms; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Bone Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Fractures, Bone; Giant Cell Tumors; Lung Neoplasms; Lymphoma, Non-Hodgkin; Osteoarthritis, Hip; Osteogenesis Imperfecta; Osteonecrosis; Pain; Plasmacytoma; Reflex Sympathetic Dystrophy; Sarcoma; Sarcoma, Ewing; Spinal Cord Injuries; Bone Diseases; Multiple Myeloma; Neoplasm Metastasis; Osteitis Deformans; Osteoporosis; Osteoporosis, Postmenopausal; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant

Farnesyl diphosphate synthase inhibitor


Enzyme Approved DIABETES DRUGS & ENDOCRINOLOGY; OTHER; UROLOGY AND KIDNEY INTRAVENOUS Fabry Disease Globotriosylceramide hydrolytic enzyme


Protein Approved DIABETES DRUGS & ENDOCRINOLOGY; MUSCULOSKELETAL; OTHER SUBCUTANEOUS Breast Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Prostatic Neoplasms; Sarcoma; Fibrous Dysplasia, Polyostotic; Pituitary Diseases; Acromegaly Growth hormone receptor antagonist


Small molecule Approved DIABETES DRUGS & ENDOCRINOLOGY; OTHER ORAL Polycystic Ovary Syndrome; Renal Insufficiency; Diabetes Mellitus, Type 1; Obesity; Diabetic Nephropathies; Heart Failure; Diabetes Mellitus; Diabetes Mellitus, Type 2 Sodium/glucose cotransporter 2 inhibitor


Small molecule Approved DIABETES DRUGS & ENDOCRINOLOGY ORAL Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Hypertension; Renal Insufficiency; Schizophrenia; Stomach Neoplasms; Respiratory Tract Diseases; Severe Acute Respiratory Syndrome; Diabetes Mellitus; Diabetes Mellitus, Type 2 Dipeptidyl peptidase IV inhibitor


Small molecule Approved DIABETES DRUGS & ENDOCRINOLOGY; OTHER ORAL Glycogen Storage Disease Type I; Hyponatremia; Inappropriate ADH Syndrome; Kidney Calculi; Kidney Diseases; Non-alcoholic Fatty Liver Disease; Polycystic Ovary Syndrome; Prediabetic State; Diabetes, Gestational; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Heart Failure; Insulin Resistance; Myocardial Infarction; Renal Insufficiency, Chronic; Diabetes Mellitus; Diabetes Mellitus, Type 2 Sodium/glucose cotransporter 2 inhibitor

Small molecule

Approved

DIABETES DRUGS & ENDOCRINOLOGY; OTHER

ORAL

Glycogen Storage Disease Type I; Hyponatremia; Inappropriate ADH Syndrome; Kidney Calculi; Kidney Diseases; Non-alcoholic Fatty Liver Disease; Polycystic Ovary Syndrome; Prediabetic State; Diabetes, Gestational; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Heart Failure; Insulin Resistance; Myocardial Infarction; Renal Insufficiency, Chronic; Diabetes Mellitus; Diabetes Mellitus, Type 2

Sodium/glucose cotransporter 2 inhibitor


Protein Approved DIABETES DRUGS & ENDOCRINOLOGY INJECTION Diabetes Mellitus, Type 1; Heart Failure; Diabetes Mellitus; Diabetes Mellitus, Type 2 Glucagon-like peptide 1 receptor agonist


Small molecule Approved DIABETES DRUGS & ENDOCRINOLOGY INTRAMUSCULAR; ORAL Carcinoma, Renal Cell; Coronary Disease; Sexual Dysfunction, Physiological; Spinal Cord Injuries; Aging; Malnutrition; Respiratory Insufficiency; Hypogonadism; Klinefelter Syndrome; Neoplasms; Orchitis Androgen Receptor agonist


Small molecule Approved DIABETES DRUGS & ENDOCRINOLOGY; OTHER ORAL Acute Kidney Injury; Atrial Fibrillation; Aging; Alzheimer Disease; Pancreatic Neoplasms; Prostatic Neoplasms; Breast Neoplasms; Cystinuria; Diabetic Nephropathies; Heart Failure, Diastolic; Hyperuricemia; Metabolic Syndrome; Obesity; Weight Loss; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Heart Failure; Non-alcoholic Fatty Liver Disease; Polycystic Ovary Syndrome; Renal Insufficiency, Chronic; Severe Acute Respiratory Syndrome; Diabetes Mellitus Sodium/glucose cotransporter 2 inhibitor

Small molecule

Approved

DIABETES DRUGS & ENDOCRINOLOGY; OTHER

ORAL

Acute Kidney Injury; Atrial Fibrillation; Aging; Alzheimer Disease; Pancreatic Neoplasms; Prostatic Neoplasms; Breast Neoplasms; Cystinuria; Diabetic Nephropathies; Heart Failure, Diastolic; Hyperuricemia; Metabolic Syndrome; Obesity; Weight Loss; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Heart Failure; Non-alcoholic Fatty Liver Disease; Polycystic Ovary Syndrome; Renal Insufficiency, Chronic; Severe Acute Respiratory Syndrome; Diabetes Mellitus

Sodium/glucose cotransporter 2 inhibitor


Protein Approved DIABETES DRUGS & ENDOCRINOLOGY; OTHER INJECTION Diabetes Mellitus, Type 1; Polydipsia; Smoking Cessation; Diabetes Mellitus; Diabetes Mellitus, Type 2 Glucagon-like peptide 1 receptor agonist


Protein Approved DIABETES DRUGS & ENDOCRINOLOGY; OTHER INJECTION Osteoporosis, Postmenopausal; Psoriasis; Osteoporosis; Hypocalcemia; Hypoparathyroidism Parathyroid hormone receptor agonist


Combination Approved DIABETES DRUGS & ENDOCRINOLOGY; OTHER ORAL Unknown Unknown


Combination Approved DIABETES DRUGS & ENDOCRINOLOGY; MUSCULOSKELETAL; OTHER; PREGNANCY AND GYNECOLOGY ORAL-28 Unknown Unknown


Combination Approved DIABETES DRUGS & ENDOCRINOLOGY; OTHER ORAL Unknown Unknown


Unknown Approved DIABETES DRUGS & ENDOCRINOLOGY INJECTION Unknown Unknown


Combination Approved DIABETES DRUGS & ENDOCRINOLOGY; OTHER ORAL Unknown Unknown


Protein Approved DIABETES DRUGS & ENDOCRINOLOGY; OTHER SUBCUTANEOUS Unknown Unknown


Protein Approved DIABETES DRUGS & ENDOCRINOLOGY; OTHER INJECTION; SUBCUTANEOUS Unknown Unknown


Combination Approved DIABETES DRUGS & ENDOCRINOLOGY; OTHER ORAL Unknown Unknown


Combination Approved DIABETES DRUGS & ENDOCRINOLOGY; OTHER ORAL Unknown Unknown


Small molecule Approved DIABETES DRUGS & ENDOCRINOLOGY; GASTROINTESTINAL; OTHER INJECTION; NASAL; ORAL Vitamin B 12 Deficiency; Fallopian Tube Neoplasms; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Cutaneous; Meningeal Carcinomatosis; Mycosis Fungoides; Ovarian Neoplasms; Peritoneal Neoplasms; Pulmonary Alveolar Proteinosis; Sezary Syndrome; Arthralgia; Atherosclerosis; Autistic Disorder; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Depressive Disorder; Diabetic Neuropathies; Head and Neck Neoplasms; Heart Failure; HIV Infections; Lung Neoplasms; Lymphoma; Lymphoma, T-Cell, Peripheral; Mesothelioma; Myocardial Infarction; Myocardial Ischemia; Nasopharyngeal Neoplasms; Prostatic Neoplasms, Castration-Resistant; Psychotic Disorders; Severe Acute Respiratory Syndrome; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Pregnancy; Psoriasis; Anemia; Anemia, Iron-Deficiency; Diabetes Mellitus, Type 2; Folic Acid Deficiency; Kidney Failure, Chronic; Nasal Obstruction; Osteoporosis; Vitamin B Deficiency Supplement

Small molecule

Approved

DIABETES DRUGS & ENDOCRINOLOGY; GASTROINTESTINAL; OTHER

INJECTION; NASAL; ORAL

Vitamin B 12 Deficiency; Fallopian Tube Neoplasms; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Cutaneous; Meningeal Carcinomatosis; Mycosis Fungoides; Ovarian Neoplasms; Peritoneal Neoplasms; Pulmonary Alveolar Proteinosis; Sezary Syndrome; Arthralgia; Atherosclerosis; Autistic Disorder; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Depressive Disorder; Diabetic Neuropathies; Head and Neck Neoplasms; Heart Failure; HIV Infections; Lung Neoplasms; Lymphoma; Lymphoma, T-Cell, Peripheral; Mesothelioma; Myocardial Infarction; Myocardial Ischemia; Nasopharyngeal Neoplasms; Prostatic Neoplasms, Castration-Resistant; Psychotic Disorders; Severe Acute Respiratory Syndrome; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Pregnancy; Psoriasis; Anemia; Anemia, Iron-Deficiency; Diabetes Mellitus, Type 2; Folic Acid Deficiency; Kidney Failure, Chronic; Nasal Obstruction; Osteoporosis; Vitamin B Deficiency

Supplement


Combination Approved DIABETES DRUGS & ENDOCRINOLOGY; OTHER ORAL Unknown Unknown


Combination Approved DIABETES DRUGS & ENDOCRINOLOGY; OTHER ORAL Unknown Unknown